What Is Aspadol Er 200 Mg?
Aspadol Extended Release (ER) 200 tablet is a pain medication prescribed for moderate to severe pain in adults. In 2008, the FDA approved the centrally-acting opioid painkiller Tapentadol under the brand name Aspadol. Its dual mechanism of action offers relief from a broad range of body pains within 30 minutes.
Aspadol extended-release (ER) tablets are different from immediate-release (IR) formulations based on their ability to disintegrate. The ER medications are formulated to gradually release the active ingredient (tapentadol) into the system. This provides extended pain relief for up to 12 hours, significantly longer than Tapentadol or Aspadol IR tablets, which offer relief for only 4 to 6 hours.
List Of Ingredients
Aspadol ER 200 mg has four main inactive ingredients in addition to its active ingredient, Tapentadol. These are alpha-tocopherol (vitamin E), hypromellose, polyethylene glycol, and polyethylene oxide.
The film coating of the tablet contains polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide, and the colorant FD&C Blue #2 aluminum lake.
Uses Of Aspadol Er 200 Mg
Aspadol 200 mg tablets are recommended for severe and persistent pain in adults that require extended treatment. It is approved for treating moderate to severe acute pain associated with lower back pain, osteoarthritis pain, postoperative pain, and fibromyalgia. It is also prescribed for diabetic neuropathy, which requires round-the-clock pain relief.
Dosage Information
For moderate to severe acute pain, 200 mg of Aspadol ER can be taken every 12 hours.
The maximum dose of Aspadol ER tablets is 500 mg daily.
How To Take Aspadol Er 200Mg?
- Swallow the Aspadol 200 mg tablet with water.
- Crushing or chewing the Aspadol 200 tablet can result in the release of the active compound at a higher level than recommended, leading to an overdose.
- Take the ER tablet at the same time for better results.
- People with nausea can take the medication with food.
- Avoid abrupt discontinuation without consulting a doctor to prevent withdrawal symptoms.
Alternative Dose
Beginners are recommended to start with a lower dose of Tapentadol, such as Topcynta 50 mg or Aspadol 100 mg. Depending on the severity of the pain, the dose can be increased
Note- It is essential to note that the above suggested alternative doses are immediate-release formulas that will work for up to 6 hours and require multiple doses. So, any change in the formulation and dosage strength must be done after consulting a doctor.
Side Effects
The common side effects of Aspadol ER tablets include dizziness, Nausea, dry mouth, drowsiness, and tiredness.
Contact a doctor immediately if you experience shortness of breath, chest pain, fast heartbeat, agitation, hallucinations, heavy sweating, and feeling overheated.
Precautions And Warnings
- Prolonged use of Aspadol ER 200 during pregnancy can cause opioid withdrawal syndrome in the baby.
- It is not recommended to breastfeed while taking Aspadol ER, as it can affect the growth and development of the infant.
- Do not drive or operate heavy machinery while taking Aspadol ER 200 mg tablet, as it can cause dizziness and drowsiness.
- Taking Aspadol ER with alcohol can cause an overdose by increasing the levels of the drug in the blood.
- Accidental ingestion of a single dose of Aspadol ER 200 tablet can result in an overdose. In such cases, consult a doctor immediately.
Storage And Disposal
- Proper disposal involves flushing the medication down the toilet or wrapping it in to keep it away from direct sunlight and moisture.
- Dispose of the medication properly by flushing it down the toilet or first wrapping it in a piece of paper before putting it in the trash can.
Drug Interaction
The intake of Aspadol 200 tablets with other medication (both over-the-counter and prescription) and supplements can cause drug interaction. It can result in a higher risk of side effects and lower effectiveness.
The table below lists medications and supplements that should be taken with Aspadol 200 tablets.
Reviews
There are no reviews yet.